» Articles » PMID: 38214542

The Oncolytic Activity of Zika Viral Therapy in Human Neuroblastoma In Vivo Models Confers a Major Survival Advantage in a CD24-dependent Manner

Overview
Specialty Oncology
Date 2024 Jan 12
PMID 38214542
Authors
Affiliations
Soon will be listed here.
Abstract

Significance: Sensitivity to the tumoricidal effect of ZIKV on high-risk neuroblastoma tumors is dependent on CD24 expression, offering a prognostic marker for this oncolytic therapy in an extensive array of CD24-expressing cancers.

Citing Articles

Neuroblastoma-A Review of Combination Immunotherapy.

Pieniazek B, Cencelewicz K, Bzdziuch P, Mlynarczyk L, Lejman M, Zawitkowska J Int J Mol Sci. 2024; 25(14).

PMID: 39062971 PMC: 11276848. DOI: 10.3390/ijms25147730.


Zika Virus: A Neurotropic Warrior against High-Grade Gliomas-Unveiling Its Potential for Oncolytic Virotherapy.

Calderon-Pelaez M, Maradei Anaya S, Bedoya-Rodriguez I, Gonzalez-Ipuz K, Vera-Palacios D, Buitrago I Viruses. 2024; 16(4).

PMID: 38675903 PMC: 11055012. DOI: 10.3390/v16040561.

References
1.
Ward E, DeSantis C, Robbins A, Kohler B, Jemal A . Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014; 64(2):83-103. DOI: 10.3322/caac.21219. View

2.
Shen Y, Nemunaitis J . Fighting cancer with vaccinia virus: teaching new tricks to an old dog. Mol Ther. 2005; 11(2):180-95. DOI: 10.1016/j.ymthe.2004.10.015. View

3.
Wenger R, Rochelle J, Seldin M, Kohler G, Nielsen P . The heat stable antigen (mouse CD24) gene is differentially regulated but has a housekeeping promoter. J Biol Chem. 1993; 268(31):23345-52. View

4.
Wang L, Lin S, Rammohan K, Liu Z, Liu J, Liu R . A dinucleotide deletion in CD24 confers protection against autoimmune diseases. PLoS Genet. 2007; 3(4):e49. PMC: 1847692. DOI: 10.1371/journal.pgen.0030049. View

5.
Smith J, Jeng S, McWeeney S, Hirsch A . A MicroRNA Screen Identifies the Wnt Signaling Pathway as a Regulator of the Interferon Response during Flavivirus Infection. J Virol. 2017; 91(8). PMC: 5375670. DOI: 10.1128/JVI.02388-16. View